Dashboard
Financial statements
A

Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025
Revenue FY2025
$6.9B
3y CAGR +0.5% P17
Net income FY2025
$1.3B
Net margin +18.8% P77
Total assets FY2025
$12.7B
ROA +10.2% P72
Operating cash flow FY2025
$1.6B
FCF margin +16.6% P55
20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 10 years
Total assets $12.7B
Total liabilities $6.0B
Shareholders equity $6.7B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents +34.6% -16.4% +51.0% -29.0% +3.0% +4.3% -38.5% -16.1% +17.0%
Short Term Investments
Accounts Receivable +12.3% +2.6% -8.1% +19.9% +12.9% +11.6% +19.8% +7.2% +14.7%
Inventory +5.5% -5.7%
Prepaid Expenses -12.3% +21.9%
Other Current Assets -12.3% +21.9%
Total Current Assets +16.0% -5.4% +10.8% -0.6% +11.2% +7.1% -17.1% -7.7% +14.7%
Property,Plant and Equipment +13.8% +40.0% +15.5% +16.4% +11.8% -0.6% +3.4% +8.6% +18.5%
Operating Lease Assets +3.4% +14.9% +2.7% -15.7% +1.7%
Goodwill -0.1% +13.1% +0.2% -0.6% +10.4% +0.3% +20.9% +14.0% +3.6%
Intangible Assets -18.6% +15.2%
Long Term Investments -24.0% +6.7% -15.9% +5.4% +17.1% +54.9% +50.0% -50.7% +2.2%
Other Noncurrent Assets +16.4% +28.5% +3.2% -16.3% +5.7% +27.0% +80.2% -14.0% -12.8%
Total Assets +7.4% +10.1% +2.2% -1.6% +11.2% +1.9% +10.7% +1.4% +8.1%
Liabilities
Accounts Payable +5.6% +29.2% -27.9% +30.0% +26.0% +0.0% +4.1% +11.5% +18.7%
Accrued Liabilities -14.8% +17.1% -29.4% -6.0% +23.7% -27.0% +53.7% +11.6% +14.9%
Deferred Revenue +14.7% +7.7%
Current Portion of Long Term Debt +575.6%
Total Current Liabilities +23.9% +18.2% -13.9% +9.0% +16.4% -29.5% +77.6% -7.3% +33.7%
Long Term Debt -8.8% +22.3% +0.1% +0.1% +19.5% +27.5% -0.4% -0.1% -5.4%
Deferred Revenue Noncurrent +14.7% +7.7%
Other Noncurrent Liabilities -19.9% +21.2% -11.0% -18.7% +7.3% +29.8% -37.8% +159.7% -13.6%
Total Liabilities +0.6% +20.9% -5.9% -1.7% +11.8% +1.1% +18.5% +10.6% +1.2%
Equity
Preferred Stock
Common Stock +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% -50.0%
Additional Paid In Capital +2.3% +1.2% +1.2% +0.1% +0.2% +0.6% -0.6% +0.2% -42.1%
Retained Earnings +85.2% -4.1%
Treasury Stock
Accumulated Other Comprehensive Income +25.9% +6.7%
Total Stockholders Equity +14.3% +0.9% +10.2% -1.6% +10.6% +2.6% +4.0% -5.5% +13.9%
Total Liabilitiesand Equity +7.4% +10.1% +2.2% -1.6% +11.2% +1.9% +10.7% +1.4% +8.1%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +52.4% +54.3% +50.7% +54.4% +53.9% +53.1% +54.3% +54.5% +53.6% +52.3%
Operating margin +21.3% +22.9% +19.8% +23.6% +21.3% +15.8% +18.2% +18.4% +18.0% +14.6%
Net margin +18.8% +19.8% +18.1% +19.1% +13.5% +20.7% +6.4% +15.3% +11.0%
FCF margin +16.6% +21.1% +21.6% +14.9% +20.5% +15.0% +16.8% +18.5% +15.9% +15.6%
Growth
Revenue CAGR (3y) +0.5% +1.0% +8.6% +9.9% +8.7% +6.1% +7.1% +6.8% +3.4% +2.6%
Returns
ROE +19.3% +21.9% +21.2% +22.5% +14.8% +22.6% +6.9% +14.2% +10.9%
ROA +10.2% +10.9% +11.5% +11.3% +7.5% +11.3% +3.7% +8.1% +5.9%
ROIC +16.2% +15.8% +17.9% +23.0% +20.3% +14.6% +16.3% +21.9% +19.4% +15.9%
Liquidity
Current ratio 1.96x 2.09x 2.61x 2.03x 2.22x 2.33x 1.53x 3.29x 3.30x 3.85x
Quick ratio 1.40x 1.40x 1.80x 1.32x 1.56x 1.69x 1.11x 2.58x 2.69x 3.09x
Leverage
D/E 0.89x 1.01x 0.84x 0.99x 0.99x 0.98x 0.99x 0.87x 0.74x 0.84x
Interest coverage 13.21x 15.50x 14.21x 19.26x 16.63x 10.85x 12.72x 12.05x 10.22x 8.54x
Efficiency
Asset turnover 0.55x 0.55x 0.63x 0.65x 0.59x 0.55x 0.55x 0.58x 0.53x 0.54x
Cash conversion cycle +128d +127d +135d +128d +116d +124d +116d +106d +107d +105d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025
Market cap $32.9B
P/E 25.26x
P/S 4.74x
P/B 4.88x
EV $34.5B
EV/EBITDA 19.51x
FCF yield +3.5%
Dividend yield +0.9%

Notes

Your annotations

Not watched
Saving notes adds A to your watchlist.